ArticlePharmaceutics2022

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.

Paul Thoueille et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.